Survival benefit of surgery vs radiotherapy alone to patients with stage IA lung adenocarcinoma: a propensity score-matched analysis
Radiotherapy alone can be used as an option for patients with stage IA lung adenocarcinoma who cannot tolerate surgery, but the benefit to patients is limited, and surgical treatment may still be the best choice.
Authors
- Guangyao Shan (ORCID: https://orcid.org/0000-0002-2993-5817)
- Zhencong Chen (ORCID: https://orcid.org/0000-0003-2763-9667)
- Valeria Besskaya (ORCID: https://orcid.org/0009-0002-6645-7823)
- Zhengyang Hu (ORCID: https://orcid.org/0000-0003-4541-1826)
- Yanjun Yi
- Junjie Xi (ORCID: https://orcid.org/0000-0002-1766-7149)
- Dejun Zeng
- Ming Li
- Qun Wang (ORCID: https://orcid.org/0000-0003-4853-1727)
- Zongwu Lin (ORCID: https://orcid.org/0000-0002-8868-4405)
- Cheng Zhan (ORCID: https://orcid.org/0000-0001-8745-9276)
Institutions
- Fudan University (CN)
- Zhongshan Hospital (CN)
Publication Details
- Journal
- European journal of medical research
- Published
- 2025-03-15
- DOI
- https://doi.org/10.1186/s40001-025-02436-3
- Citations
- 2
- Primary Topic
- Lung Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 3.04
Funders
- Natural Science Foundation of Shanghai
- National Natural Science Foundation of China